Biocardia announces japanese patent for helix™ biotherapeutic delivery system

Sunnyvale, calif., march 10, 2025 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the japan patent office has granted japanese patent no. 7641330 titled “radial and transendocardial delivery catheter” with a patent term that will expire on or after september 30, 2034.
BCDA Ratings Summary
BCDA Quant Ranking